SLNO Soleno Therapeutics Inc

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.

$0.57
As of 12/03/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  11/13/2014
Outstanding shares:  79,806,487
Average volume:  237,663
Market cap:   $49,480,022
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    834203200
ISIN:        US8342032005
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.26
PS ratio:   0.00
Return on equity:   -153.12%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy